The 52nd APAN Meeting -APSC Cloud Webinar of Cardiovascular Diseases
Program |
Mailing List |
Connection Information |
Files |
Report |
ver 2.85
The 52nd APAN Meeting -APSC Cloud Webinar of Cardiovascular Diseases
* For more information, please refer to the TEMDEC policy.
The 52nd APAN Meeting -APSC Cloud Webinar of Cardiovascular Diseases
| Local Time at Main Venue | 2021.08.04(Wed) 16:30 - 105min, Taipei, TW (UTC+08:00) |
| Organizer | Jiunn-Lee Lin |
| Topic | Assessment & Management of Valvular Heart Diseases (II) : Aortic Valve Disease |
| Contents | Cardiology |
| Style | Conference |
| Connection Method | Zoom, Streaming |
| Server At | https://us02web.zoom.us/j/9996789876 |
| Access Information |
 |
| Brief Description | "Valvular heart disease have been become a new target of innovation in medical device technology, particularly for minimally invasive or even noninvasive therapy. Transcatheter aortic valve replacement is the most well-known example. In the Aortic Valve Disease session (II) of APSC Cloud Forum of Valvular Heart Diseases, we’d review the updated severity classification of aortic valve stenosis and aortic regurgitation by cardiac imaging, followed by current medical interventional versus surgical management of aortic valve stenosis in congenital (bicuspid) and degenerative (tricuspid) mechanism, aortic valve stenosis in HFrEF especially when low-flow and low gradient, as well as timing of surgery for severe aortic regurgitation. From congenital to degenerative, from normal to failing heart, aortic valve stenosis and aortic regurgitation management are presenting a new world of biotechnology-aiding medicine." |
Key Members
| Chair | Jiunn-Lee Lin | National Taiwan University | TW |
| Co-Chair 1 | - | - | - |
| Co-Chair 2 | - | - | - |
| Chief Engineer 1 | Ti-Chuang Chiang | National Taiwan University | TW |
| Chief Engineer 2 | - | - | - |
| Chief Engineer 3 | - | - | - |
| Chief Engineer 4 | - | - | - |
Connecting Institutions
Red is to be decided| City, Country | Institution | Moderator | Local Engineer | |
|---|---|---|---|---|
| 1(Main). | Taipei, TW | National Taiwan University | Hsi-Yu Yu | Ti-Chuang Chiang |
| 2. | Taipei, TW | Taiwan Heart Foundation | - | - |
| 3. | Singapore, SG | National Heart Centre Singapore | Ewe See Hooi | - |
| 4. | Abu Dhabi, AE | Cleveland Clinic Abu Dhabi | Mahmoud Traina | - |
| 5. | Toyohashi, JP | Toyohashi Heart Center | Masanori Yamamoto | - |
| 6. | Bandar Seri Begawan, BN | RIPAS hospital | Lau Bee-Ngo | - |
Schedule
| Main venue | Localtime | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.Taipei, TW (UTC+08:00) | Contents | Presenter | UTC+08:00 (Institution No. 2, 3, 6) | UTC+04:00 (Institution No. 4) | UTC+09:00 (Institution No. 5) | |||||||||||||||||
| 2021.08.04 15:30 - 16:30 | Connection starts for Final Testing | 2021.08.04 15:30 - 16:30 | 2021.08.04 11:30 - 12:30 | 2021.08.04 16:30 - 17:30 | ||||||||||||||||||
| 16:30 - 16:33 | Open | Hsi-Yu Yu(National Taiwan University) | 16:30 - 16:33 | 12:30 - 12:33 | 17:30 - 17:33 | |||||||||||||||||
| 16:33 - 16:53 | Assessment of severity of aortic valve stenosis and aortic regurgitation by cardiac imaging: rheumatic vs. nonrheumatic | Ewe See Hooi(National Heart Centre Singapore) | 16:33 - 16:53 | 12:33 - 12:53 | 17:33 - 17:53 | |||||||||||||||||
| 16:53 - 16:58 | Q & A | Chair 1, 2 & all | 16:53 - 16:58 | 12:53 - 12:58 | 17:53 - 17:58 | |||||||||||||||||
| 16:58 - 17:18 | Assessment and interventional management of severe tricuspid vs bicuspid aortic valve stenosis: TAVR, SAVR, or Bentall procedure? | Mahmoud Traina(Cleveland Clinic Abu Dhabi) | 16:58 - 17:18 | 12:58 - 13:18 | 17:58 - 18:18 | |||||||||||||||||
| 17:18 - 17:23 | Q & A | Chair 1, 2 & all | 17:18 - 17:23 | 13:18 - 13:23 | 18:18 - 18:23 | |||||||||||||||||
| 17:23 - 17:43 | Decision-making in best management of aortic valve stenosis in heart failure with reduced EF: GDMT, TAVR or SAVR? | Masanori Yamamoto(Toyohashi Heart Center) | 17:23 - 17:43 | 13:23 - 13:43 | 18:23 - 18:43 | |||||||||||||||||
| 17:43 - 17:48 | Q & A | Chair 1, 2 & all | 17:43 - 17:48 | 13:43 - 13:48 | 18:43 - 18:48 | |||||||||||||||||
| 17:48 - 18:08 | Timing of surgical intervention for severe aortic regurgitation with rheumatic or nonrheumatic mechanism: any point of no return ? | Lau Bee-Ngo(RIPAS hospital) | 17:48 - 18:08 | 13:48 - 14:08 | 18:48 - 19:08 | |||||||||||||||||
| 18:08 - 18:13 | Q & A | Chair 1, 2 & all | 18:08 - 18:13 | 14:08 - 14:13 | 19:08 - 19:13 | |||||||||||||||||
| 18:13 - 18:15 | Close | Ewe See Hooi(National Heart Centre Singapore) | 18:13 - 18:15 | 14:13 - 14:15 | 19:13 - 19:15 | |||||||||||||||||
Precautions
- The conference will be recorded by the photos and movies.
- Pictures taken at the conference will be published in TEMDEC home page, annual report and conference presentations.
- Do not present the personal information of patients any in oral and presentation materials without obtaining the patient's consent.
- The conference will be delivered simultaneously by streaming.
* For more information, please refer to the TEMDEC policy.